SearchResearch
Beta
Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

Genomic Sequencing of Colorectal Adenocarcinomas

Request Access

Demographics (3)

  • Age - Age of the participant at the time of collection of their first or only sample, or the age of the participant at a specific interval or visit (phv00162702.v1.p1)
  • Gender - Participant's gender as Male or Female (phv00162707.v1.p1)
  • Year of Birth - Year of birth of participant (phv00162711.v1.p1)

Disease Events (9)

  • Age at Diagnosis - Age of the participant at the time of diagnosis of their Primary Disease (phv00162703.v1.p1)
  • Cancer Stage - Stage of Cancer as appropriate for cancer type (phv00162716.v1.p1)
  • CEA - Carcinoembryonic Antigen (ng/mL) (phv00162704.v1.p1)
  • Chemotherapy - Undergone or undergoing chemotherapy treatment for cancer. (phv00162705.v1.p1)
  • Primary Disease - The main disease(s) for which the participant has been asked to donate a sample for study (phv00162708.v1.p1)
  • Radiation Therapy - Undergone or undergoing radiation therapy for cancer (phv00162710.v1.p1)
  • Sample Type - Indicates the Tumor / Normal status of a sample (phv00162713.v1.p1)
  • Tumor Percent - Estimated percent of nucleated cells that consist of tumor cells (determined by BSP if tissue sample QC'd, but may be provided by collaborator on samples BSP does not review) (phv00162715.v1.p1)
  • Tumor Type - Sample taken from Primary or Secondary/Metastatic tumor (phv00162717.v1.p1)

Race and Ethnicity (1)

Other (12)

  • BSP Notes - Comments on tissue from BSP path. Review or additional notes submitted by the collaborator (phv00162718.v1.p1)
  • CONSENT - Consent group as determined by DAC (phv00162698.v1.p1)
  • Country - The country in which the participant was living and from which their sample was collected (phv00162706.v1.p1)
  • Fibroblast and Vessel Percent - Estimated percent of nucleated cells that consist of fibroblasts and vessels (determined by BSP if tissue sample QC'd, but may be provided by collaborator on samples BSP does not review) (phv00162719.v1.p1)
  • Inflammation Percent - Estimated percent of nucleated cells that consist of inflammatory cells (determined by BSP if tissue sample QC'd, but may be provided by collaborator on samples BSP does not review) (phv00162720.v1.p1)
  • Necrosis Percent - Estimated percent of the tissue specimen that is necrotic (relative indicator of specimen quality) (phv00162721.v1.p1)
  • SAMPID - De-identified Sample ID (phv00162712.v1.p1)
  • SAMPID - Sample ID (phv00162700.v1.p1)
  • SUBJID - Unique Participant Identifier (phv00162701.v1.p1)
  • SUBJID - Subject ID (phv00162697.v1.p1)
  • SUBJID - Subject ID (phv00162699.v1.p1)
  • Tissue Site - General body site where sample was collected (phv00162714.v1.p1)